NCT03914989

Brief Summary

This study evaluates the efficacy of multi-odorant enrichment on cognitive skills, olfactory function, and quality of life.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 8, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 10, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 16, 2019

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
Last Updated

March 24, 2023

Status Verified

February 1, 2023

Enrollment Period

2.3 years

First QC Date

April 10, 2019

Last Update Submit

March 22, 2023

Conditions

Keywords

Memory preservationAge-related memory disordersInterventionLife qualityOlfaction

Outcome Measures

Primary Outcomes (1)

  • Evaluation of behavioral pattern separation ability

    Change in lure discrimination index on a computerized mnemonic discrimination task.

    1) at Baseline and 2) after 6 months of intervention

Secondary Outcomes (6)

  • Evaluation of cognition

    1) at Baseline and 2) after 6 months of intervention

  • Evaluation of depression

    1) at Baseline and 2) after 6 months of intervention

  • Evaluation of quality of life

    1) at Baseline and 2) after 6 months of intervention

  • Evaluation of olfactory function

    1) at Baseline and 2) after 6 months of intervention

  • Evaluation of change in brain structural connectivity

    1) at Baseline and 2) after 6 months of intervention

  • +1 more secondary outcomes

Study Arms (2)

Experimental group

EXPERIMENTAL

Individuals in this group receive exposure to a higher concentration of essential oil fragrances nightly.

Other: olfactory enrichment (essential oils)

Active control group

PLACEBO COMPARATOR

Individuals in this group receive exposure to a lower concentration of essential oil fragrances nightly.

Other: olfactory enrichment (essential oils)

Interventions

Participants will be exposed to either a higher or lower concentration of essential oils nightly for two hours as they are going to sleep, using a nebulizing fragrance diffuser, rotating through seven different scents, one per night.

Active control groupExperimental group

Eligibility Criteria

Age60 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Are age 60-85, male or female
  • Have normal cognition (determined at first assessment with cognitive testing)
  • Speak/read/understand English fluently
  • Have visual and auditory acuity adequate for neuropsychological and computerized testing
  • Are in good general health with no disease(s) expected to interfere with the study
  • Are willing and able to participate for the duration of the study and in all study procedures
  • Are able to smell scents
  • Are willing to refrain from using scented candles, scented oils, or air fresheners while participating in the study
  • Are willing to travel to the research site for testing
  • If interested in functional Magnetic Resonance Imaging (fMRI),
  • Are willing and able to participate in the fMRI scan.

You may not qualify if:

  • Have known fragrance sensitivities
  • Have asthma, allergies, or a fragrance sensitivity, which produces symptoms similar to those of an allergy, including runny nose, watery eyes, sneezing, or skin rash
  • Have a neurologic disease such as Parkinson's disease, multiple sclerosis, brain cyst, tumor or aneurysm
  • Have major health conditions such as uncontrolled diabetes mellitus, uncontrolled hypertension, nutritional deficiency or thyroid disease
  • Have significant psychiatric disorders such as schizophrenia, bipolar disorder, anxiety disorder, or attention-deficit hyperactivity disorder
  • Have cognitive impairment when tested at baseline (defined as a score on any neuropsychological test of 1.5 standard deviations or more outside the age norm)
  • Have had alcohol or substance abuse or dependence within the past 2 years (DSM-IV criteria)
  • Smoke cigarettes, e-cigarettes, cigars, marijuana, or any other substance that could produce an interfering odor for the study.
  • If interested in functional Magnetic Resonance Imaging (fMRI),
  • MRI contraindications, (e.g. pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments or foreign objects in the eyes, skin or body).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California Irvine

Irvine, California, 92697, United States

Location

MeSH Terms

Conditions

Memory DisordersAnosmia

Interventions

Oils, Volatile

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsOlfaction DisordersSensation Disorders

Intervention Hierarchy (Ancestors)

OilsLipids

Study Officials

  • Michael Leon, PhD

    University of California, Irvine

    PRINCIPAL INVESTIGATOR
  • Michael Yassa, PhD

    University of California, Irvine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Both the participants and the assessors will be blinded to the group assignments.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to either an experimental group or an active control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 10, 2019

First Posted

April 16, 2019

Study Start

March 8, 2019

Primary Completion

June 30, 2021

Study Completion

June 30, 2021

Last Updated

March 24, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations